Abstract: Aqueous formulations of indacaterol are disclosed. The formulations may find use in the treatment of respiratory disorders, inflammatory disorders, or obstructive airway diseases. Methods of using the formulations and kits comprising the formulations are also encompassed by the disclosure.
Type:
Grant
Filed:
September 29, 2021
Date of Patent:
December 19, 2023
Assignee:
AERORX THERAPEUTICS LLC
Inventors:
John Chan, Keith Try Ung, Mei-Chang Kuo, John Nigel Pritchard